File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/0306-3623(92)90239-G
- Scopus: eid_2-s2.0-0026666746
- PMID: 1426930
- WOS: WOS:A1992JL89800013
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Effects of S14001 on adrenergic neuroeffector interaction in isolated canine saphenous veins
Title | Effects of S14001 on adrenergic neuroeffector interaction in isolated canine saphenous veins |
---|---|
Authors | |
Issue Date | 1992 |
Publisher | Elsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/vph |
Citation | General Pharmacology, 1992, v. 23 n. 5, p. 867-872 How to Cite? |
Abstract | The effects of (S)fluoro-6(morpholinyl-2 methoxy)-8-tetrahydro-1,2,3,4 quinoleine (S14001) on adrenergic neurotransmission in isolated canine saphenous veins were investigated in experiments which measured the accumulation, overflow and metabolism of 3H-norepinephrine. S14001 inhibited the accumulation of total tritium (3H-norepinephrine and 3H-metabolites of norepinephrine) in a concentration-dependent manner. Under basal conditions, S14001 increased tension and basal efflux of total tritium; the latter consisted predominantly of 3H-DOPEG. The increases in these parameters were not inhibited by desmethylimipramine (DMI). During electrical stimulation, S14001 increased the contraction and overflow of total tritium; the latter consisted predominantly of 3H-DOPEG. The increases in these parameters were inhibited by DMI. These experiments suggest that S14001 has dual effects on adrenergic neurotransmission in the canine saphenous vein: (a) an inhibitory action on the neuronal acumulation; and (b) a pharmacological displacement of the transmitter from adrenergic nerve terminals. |
Persistent Identifier | http://hdl.handle.net/10722/171062 |
ISSN | |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Hoshino, Y | en_US |
dc.contributor.author | Verbeuren, TJ | en_US |
dc.contributor.author | Hughes, H | en_US |
dc.contributor.author | Vanhoutte, PM | en_US |
dc.date.accessioned | 2012-10-30T06:12:02Z | - |
dc.date.available | 2012-10-30T06:12:02Z | - |
dc.date.issued | 1992 | en_US |
dc.identifier.citation | General Pharmacology, 1992, v. 23 n. 5, p. 867-872 | en_US |
dc.identifier.issn | 0306-3623 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/171062 | - |
dc.description.abstract | The effects of (S)fluoro-6(morpholinyl-2 methoxy)-8-tetrahydro-1,2,3,4 quinoleine (S14001) on adrenergic neurotransmission in isolated canine saphenous veins were investigated in experiments which measured the accumulation, overflow and metabolism of 3H-norepinephrine. S14001 inhibited the accumulation of total tritium (3H-norepinephrine and 3H-metabolites of norepinephrine) in a concentration-dependent manner. Under basal conditions, S14001 increased tension and basal efflux of total tritium; the latter consisted predominantly of 3H-DOPEG. The increases in these parameters were not inhibited by desmethylimipramine (DMI). During electrical stimulation, S14001 increased the contraction and overflow of total tritium; the latter consisted predominantly of 3H-DOPEG. The increases in these parameters were inhibited by DMI. These experiments suggest that S14001 has dual effects on adrenergic neurotransmission in the canine saphenous vein: (a) an inhibitory action on the neuronal acumulation; and (b) a pharmacological displacement of the transmitter from adrenergic nerve terminals. | en_US |
dc.language | eng | en_US |
dc.publisher | Elsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/vph | en_US |
dc.relation.ispartof | General Pharmacology | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Antidepressive Agents - Pharmacology | en_US |
dc.subject.mesh | Desipramine - Pharmacology | en_US |
dc.subject.mesh | Dogs | en_US |
dc.subject.mesh | Electric Stimulation | en_US |
dc.subject.mesh | Isometric Contraction - Drug Effects | en_US |
dc.subject.mesh | Morpholines - Pharmacology | en_US |
dc.subject.mesh | Muscle, Smooth, Vascular - Drug Effects - Innervation | en_US |
dc.subject.mesh | Neuroeffector Junction - Drug Effects - Physiology | en_US |
dc.subject.mesh | Norepinephrine - Metabolism | en_US |
dc.subject.mesh | Quinolines - Pharmacology | en_US |
dc.subject.mesh | Receptors, Adrenergic - Drug Effects - Physiology | en_US |
dc.subject.mesh | Saphenous Vein | en_US |
dc.title | Effects of S14001 on adrenergic neuroeffector interaction in isolated canine saphenous veins | en_US |
dc.type | Article | en_US |
dc.identifier.email | Vanhoutte, PM:vanhoutt@hku.hk | en_US |
dc.identifier.authority | Vanhoutte, PM=rp00238 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/0306-3623(92)90239-G | en_US |
dc.identifier.pmid | 1426930 | - |
dc.identifier.scopus | eid_2-s2.0-0026666746 | en_US |
dc.identifier.volume | 23 | en_US |
dc.identifier.issue | 5 | en_US |
dc.identifier.spage | 867 | en_US |
dc.identifier.epage | 872 | en_US |
dc.identifier.isi | WOS:A1992JL89800013 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Hoshino, Y=7202851283 | en_US |
dc.identifier.scopusauthorid | Verbeuren, TJ=7007006534 | en_US |
dc.identifier.scopusauthorid | Hughes, H=7202659303 | en_US |
dc.identifier.scopusauthorid | Vanhoutte, PM=7202304247 | en_US |
dc.identifier.issnl | 0306-3623 | - |